Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS]

NCT01134627 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: Minocycline
DRUG: Placebo

Sponsor

Merck KGaA, Darmstadt, Germany